Section Arrow
Quote
SRRK.NASDAQ
- Scholar Rock Holding Corp
Quotes are at least 15-min delayed:2025/06/05 13:59 EDT
Last
 33.49
+2.67 (+8.66%)
Day High 
34.7 
Prev. Close
30.82 
1-M High
33.3962 
Volume 
1.17M 
Bid
33.44
Ask
33.53
Day Low
30.36 
Open
30.63 
1-M Low
28.29 
Market Cap 
2.93B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 30.09 
20-SMA 30.49 
50-SMA 30.63 
52-W High 46.98 
52-W Low 6.76 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.55/-1.96
Enterprise Value
2.99B
Balance Sheet
Book Value Per Share
3.29
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CLRBCellectar Biosciences0.4195-0.0422-9.14%-- 
NCNANuCana plc0.04275-0.00335-7.27%-- 
RXRXRecursion Pharmaceuticals4.65-0.26-5.30%-- 
SCNIScinai Immunotherapeutics Ltd.2.935+0.415+16.47%1.21PE
OCGNOcugen0.9733+0.0861+9.70%-- 
Quotes are at least 15-min delayed：2025/06/05 13:59 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.